BBNX (Beta Bionics) Beginning Cash Position: $30.3 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BBNX Beta Bionics Inc BBNX
10 GF Score
Price $17.08
! 3 Warning Signs
View Full Analysis

What is Beta Bionics Beginning Cash Position?

Beta Bionics BBNX -3.20% 10 Beginning Cash Position is $30.3 Mil as of Jun. 2026. GuruFocus rates BBNX with a GF Score™ of 10/100. The stock has 3 warning signs investors should review.

Beta Bionics's Beginning Cash Position for the quarter that ended in Jun. 2026 was $30.3 Mil.

Beta Bionics's quarterly Beginning Cash Position declined from Dec. 2025 ($38.6 Mil) to Mar. 2026 ($31.7 Mil) and declined from Mar. 2026 ($31.7 Mil) to Jun. 2026 ($30.3 Mil).

Beta Bionics's annual Beginning Cash Position declined from Dec. 2023 ($27.8 Mil) to Dec. 2024 ($26.7 Mil) but then increased from Dec. 2024 ($26.7 Mil) to Dec. 2025 ($30.5 Mil).

Beta Bionics Beginning Cash Position Related Terms

Beta Bionics Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Beta Bionics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beta Bionics Beginning Cash Position Chart

Beta Bionics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
31.97 27.78 26.67 30.53

Beta Bionics Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.55 35.18 38.59 31.68 30.31
BBNX
10GF Score
Beta Bionics Inc BBNX
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beta Bionics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $30.3 Mil mean?
Beta Bionics (BBNX) has a Beginning Cash Position of $30.3 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Beta Bionics and its competitors.
Is Beta Bionics' Beginning Cash Position too high?
Beta Bionics' current Beginning Cash Position is $30.3 Mil. Overall, Beta Bionics has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Beta Bionics' Beginning Cash Position compare to SSII and SIBN?
Beta Bionics' Beginning Cash Position of $30.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Beta Bionics and its competitors. Beta Bionics's current Beginning Cash Position is $30.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beta Bionics stock overvalued right now?
Beta Bionics (BBNX) has a current Beginning Cash Position of $30.3 Mil. The current Beginning Cash Position is $30.3 Mil. Beta Bionics' overall GF Score™ is 10/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Beta Bionics (BBNX), the current Beginning Cash Position is $30.3 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beta Bionics Business Description

Address 11 Hughes, Irvine, CA, USA, 92618
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
10GF Score

Get the complete analysis for BBNX

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.08
Price